Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir

Figure 1 Serum hepatitis C virus RNA levels and liver inflammation decrease rapidly with sofosbuvir and ledipasvir therapy. A: Serum hepatitis C virus RNA levels of patients who all responded to therapy (n = 13). A response to sofosbuvir and ledipasvir therapy was defined as undetectable viremia at end of treatment (week 24); (B) Serum alanine aminotransferase. (C) Serum aspartate aminotransferase. HCV: Hepatitis C virus; Lloq: Lower limit of quantitation; Tnd: Target not detected; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase.